TNYA

Bullish

Tenaya Therapeutics presents new RIDGE-1 trial results showing arrhythmia reduction in PKP2-associated ARVC

Tenaya Therapeutics announced promising interim results from its RIDGE-1 Phase 1b/2 trial for TN-401, an investigational gene therapy for PKP2-associa...

Traders Union 50 mins ago 0

Bullish

Tenaya Therapeutics Reports Significant Reductions in Premature Ventricular Contractions in Interim Results from TN-401 Gene Therapy Clinical Trial

Tenaya Therapeutics released interim results from its RIDGE™-1 Phase 1b/2 clinical trial for TN-401 gene therapy, targeting PKP2-associated arrhythmog...

Quiver Quantitative 44 mins ago 0

Bullish

Early TN-401 gene therapy trial eases dangerous heart rhythms

Tenaya Therapeutics (NASDAQ: TNYA) announced positive interim data from Cohorts 1 and 2 of its RIDGE-1 Phase 1b/2 clinical trial for TN-401 gene thera...

Stock Titan 34 mins ago 0